Clinical trial
Growth Response in Short Children Suffering From a Disease With Growth…
NCT00488124 · University of Erlangen-Nürnberg Medical School, Other · Completed
Key facts
| NCT number | NCT00488124 |
|---|---|
| Title | Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin |
| Official title | Evaluation of Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin: A Prospective, Longitudinal Non-randomised, Open, Phase II Study |
| Acronym | ISS |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Short Stature |
| Intervention type | Drug |
| Interventions | somatropin (Genotropin® treatment) |
| Enrollment | 120 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Jun 19, 2007 |
| Last update posted | Dec 14, 2020 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: